Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study

Objective Among adults with type 2 diabetes (T2D), several (but not all) studies show that being overweight (body mass index (BMI): 25.0–29.9 kg/m2) or obese I (BMI: 30.0–34.9 kg/m2) near the time of diagnosis, is unexpectedly associated with reduced all-cause mortality compared with normal weight—the obesity paradox. We addressed whether this observation is causal (eg, a true protective effect); due to confounding (including effect modification); or due to selection (‘collider’) bias. Research design and methods We performed a matched population-level cohort study using primary care records from Salford, UK (1995–2012) in 10 464 patients with incident T2D paired (1:3) with 31 020 individuals who never developed T2D. We estimated HRs for associations of BMI with all-cause mortality using Cox models, stratified by smoking status. Results Median follow-up was 8.7 years. For never smokers, the hazard of all-cause mortality increased from 25 kg/m2, in a linear manner, with increasing BMI in the T2D cohort (HR per 5 kg/m2: 1.23, ptrend<0.001) and in the non-diabetes cohort (HR per 5 kg/m2: 1.34, ptrend<0.001). In contrast, among ever smokers, BMI-mortality relationships were U-shaped in the T2D and non-diabetes cohorts. Evidence of the obesity paradox in ever smokers, with and without T2D, argued against a selection bias, but supported a contribution of effect modification by smoking (pinteraction=0.009). Results were stable to various sensitivity analyses. Conclusions In this cohort, the obesity paradox is mainly explained by smoking as an effect modifier. These findings indicate that the obesity paradox does not challenge standard weight management recommendations among T2D patients.

[1]  A. Woodcock,et al.  Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice. , 2016, The New England journal of medicine.

[2]  V. Beral,et al.  Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents , 2016, The Lancet.

[3]  A. Renehan,et al.  The Obesity Paradox in Cancer: a Review , 2016, Current Oncology Reports.

[4]  I. Janszky,et al.  BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants , 2016, British Medical Journal.

[5]  Iain Buchan,et al.  Collider Bias Is Only a Partial Explanation for the Obesity Paradox , 2016, Epidemiology.

[6]  C. Hsieh,et al.  Association of body mass index with all-cause mortality in patients with diabetes: a systemic review and meta-analysis. , 2016, Cardiovascular diagnosis and therapy.

[7]  F. Hu,et al.  Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. , 2015, The lancet. Diabetes & endocrinology.

[8]  G. Sergi,et al.  Inverse relationship between body mass index and mortality in older nursing home residents: a meta‐analysis of 19,538 elderly subjects , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[9]  Deepak L. Bhatt,et al.  Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis. , 2015, European heart journal.

[10]  S. Anker,et al.  Protective overweight in cardiovascular disease: moving from 'paradox' to 'paradigm'. , 2015, European heart journal.

[11]  S. Preston,et al.  Smoking and reverse causation create an obesity paradox in cardiovascular disease , 2015, Obesity.

[12]  K. Michaud,et al.  Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis , 2015, Arthritis & rheumatology.

[13]  J. Cleland,et al.  The Obesity Paradox in Type 2 Diabetes Mellitus: Relationship of Body Mass Index to Prognosis , 2015, Annals of Internal Medicine.

[14]  4. Foundations of Care: Education, Nutrition, Physical Activity, Smoking Cessation, Psychosocial Care, and Immunization , 2014, Diabetes Care.

[15]  S. Heymsfield,et al.  Body Mass Index and the Risk of All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus , 2014, Circulation.

[16]  J. Dixon,et al.  BMI and mortality among adults with incident type 2 diabetes. , 2014, The New England journal of medicine.

[17]  K. Khunti,et al.  Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease , 2014, Diabetes, obesity & metabolism.

[18]  J. Manson,et al.  Body-mass index and mortality among adults with incident type 2 diabetes. , 2014, The New England journal of medicine.

[19]  M. Hernán,et al.  Body Mass Index, Diabetes, and Mortality in French Women: Explaining Away a “Paradox” , 2014, Epidemiology.

[20]  S. Wild,et al.  Association Between BMI Measured Within a Year After Diagnosis of Type 2 Diabetes and Mortality , 2013, Diabetes Care.

[21]  J. Pankow,et al.  Association of weight status with mortality in adults with incident diabetes. , 2012, JAMA.

[22]  G. Hu,et al.  Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine , 2008, Heart.

[23]  Claude Bouchard,et al.  Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.

[24]  S. Soedamah-Muthu,et al.  Mortality in people with Type 2 diabetes in the UK , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[25]  J. Robins,et al.  A Structural Approach to Selection Bias , 2004, Epidemiology.

[26]  D B Rubin,et al.  Matching using estimated propensity scores: relating theory to practice. , 1996, Biometrics.

[27]  A G Babiker,et al.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.

[28]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[29]  James Weatherall,et al.  Quantifying the longitudinal value of healthcare record collections for pharmacoepidemiology. , 2011, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[30]  P. Nilsson,et al.  Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients , 2008, Diabetologia.

[31]  D. Jacobs,et al.  Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. , 2007, Epidemiologic reviews.

[32]  O. B. O. T. I. Group,et al.  Age, body mass index and Type 2 diabetes—associations modified by ethnicity , 2003, Diabetologia.